Karen Koski analyst

Currently out of the existing stock ratings of Karen Koski, 7 are a HOLD (43.75%), 1 are a SELL (6.25%), 8 are a BUY (50%).

Karen Koski

Work Performance Price Targets & Ratings Chart

Analyst Karen Koski, carries an average stock price target met ratio of 93.33% that have a potential upside of 47.34% achieved within 416 days. Previously, Karen Koski worked at BTIG.

Karen Koski’s has documented 28 price targets and ratings displayed on 7 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on AXDX, Accelerate Diagnostics at 08-Oct-2020.

Wall Street Analyst Karen Koski

Analyst best performing recommendations are on OSUR (ORASURE TECHNOLOGIES).
The best stock recommendation documented was for AXDX (ACCELERATE DIAGNOSTICS) at 8/9/2016. The price target of $260 was fulfilled within 36 days with a profit of $40 (18.18%) receiving and performance score of 5.05.

Average potential price target upside

TTOO T2 Biosystms AXDX Accelerate Diagnostics HAE Haemonetics OSUR OraSure Technologies OXFD Oxford Immunotec Global PLC CERS Cerus TMO Thermo Fisher Scientific

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$5

$3.92 (362.96%)

$3

2 years 2 months 23 days ago
(30-Jul-2024)

6/6 (100%)

$0.11 (2.25%)

16

Hold

3 years 2 months 8 days ago
(15-Aug-2023)

3/4 (75%)

$-3.75 (-34.88%)

38

Hold

$7500

4 years 3 months 16 days ago
(07-Jul-2022)

3/5 (60%)

$3649 (94.75%)

390

Buy

$15000

5 years 11 months 18 days ago
(05-Nov-2020)

1/1 (100%)

$7050 (88.68%)

177

Hold

$200

$194.55 (3569.72%)

$200

9 years 5 months 16 days ago
(08-May-2017)

2/3 (66.67%)

$64.67 (8.94%)

172

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?